Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection-Reference-Cited by-同舟云学术

Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection

Published:2021-03 Issue: Volume:136 Page:104765
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Van Elslande Jan^ORCID,Oyaert Matthijs,Ailliet Scott,Van Ranst Marc,Lorent Natalie,Vande Weygaerde Yannick,André Emmanuel^ORCID,Lagrou Katrien,Vandendriessche Stien^ORCID,Vermeersch Pieter^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference24 articles.

1. Diagnostic performance of 7 rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients;Van Elslande;Clin. Microbiol. Infect.,2020

2. Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019;Kowitdamrong;PLoS One,2020

3. Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by 4 automated immunoassays and 3 ELISAs;Van Elslande;Clin. Microbiol. Infect.,2020

4. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans;Seow;Nat. Microbiol.,2020

5. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections;Long;Nat. Med.,2020

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Designing and optimizing clinical trials for long COVID;Life Sciences;2024-10

2. Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults;BMC Infectious Diseases;2024-08-20

3. Development of a unit conversion tool for five quantitative anti‐spike assays and agreement analysis of three qualitative anti‐nucleocapsid assays for SARS‐CoV‐2;Journal of Medical Virology;2024-07-26

4. Antibody Response to Symptomatic Infection With SARS‐CoV‐2 Omicron Variant Viruses, December 2021–June 2022;Influenza and Other Respiratory Viruses;2024-07

5. Dissecting the dynamics of SARS-CoV-2 reinfections in blood donors with pauci- or asymptomatic COVID-19 disease course at initial infection;Infectious Diseases;2024-06-13